PRESTIGE BRAND HOLDINGS INC

NYSE: PBH (Prestige Consumer Healthcare In)

Last update: 24 Jun, 7:12AM

84.39

0.95 (1.14%)

Previous Close 83.44
Open 83.43
Volume 294,482
Avg. Volume (3M) 365,027
Market Cap 4,170,106,624
Price / Earnings (TTM) 19.67
Price / Earnings (Forward) 17.54
Price / Sales 3.68
Price / Book 2.25
52 Weeks Range
64.94 (-23%) — 90.04 (6%)
Earnings Date 6 Aug 2025 - 11 Aug 2025
Profit Margin 18.86%
Operating Margin (TTM) 34.03%
Diluted EPS (TTM) 4.29
Quarterly Revenue Growth (YOY) 7.10%
Quarterly Earnings Growth (YOY) 1.40%
Total Debt/Equity (MRQ) 56.91%
Current Ratio (MRQ) 4.20
Operating Cash Flow (TTM) 251.52 M
Levered Free Cash Flow (TTM) 188.69 M
Return on Assets (TTM) 6.50%
Return on Equity (TTM) 12.30%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bearish Mixed
Drug Manufacturers - Specialty & Generic (Global) Bearish Mixed
Stock Prestige Consumer Healthcare In Mixed Bullish

AIStockmoo Score

0.1
Analyst Consensus -2.0
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages 1.0
Technical Oscillators -0.5
Average 0.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
PBH 4 B - 19.67 2.25
CTLT 11 B - - 3.23
ZTS 71 B 1.16% 28.85 15.05
TAK 48 B 1,309.29% 34.98 0.980
HLN 47 B 1.60% 25.04 2.17
RDY 13 B 52.25% 19.99 3.31

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Core
% Held by Insiders 1.43%
% Held by Institutions 107.23%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria